Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 25, 2014
Pharmacy Choice - News - U.S. Pharmaceutical Industry - July 25, 2014

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/25/14 - "Pressure-Sensing Guidewire and Sheath" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Health& Medicine Week A patent application by the inventors EHR, TIMOTHY G.J.; ASMUS, BRUCE H., filed on March 10, 2014, was made available online on July 10, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Boston Scientif
7/25/14 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for IndustryPharmacogenomic Data...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for IndustryPharmacogenomic Data Submissions. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled "Guidance for IndustryPharmacogenomic Data Submissions" has been approved by the Office of...
7/25/14 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Potential Tobacco Product Violations Reporting...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Potential Tobacco Product Violations Reporting Form. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled "Potential Tobacco Product Violations Reporting Form" has been approved by the Office of Management
7/25/14 - Agios Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Agios Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by Francesco G. Salituro, Marlborough, Massachusetts, Jeffrey O. Saunders, Concord, Massachusetts, and Shunqi Yan, Irvine, California, for "therapeutic compounds and compositions." The patent application was filed on June 29, 2010. Writt
7/25/14 - Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions
CMS recently has imposed a series of stiff sanctions against some health plans for providing inadequate access to prescription drugs. On Aug. 5, the Atlantic Information Services webinar, "Avoiding Costly Part D Sanctions: Rx Access Strategies for Plans and PBMs," will provide the details of what CMS is looking for and steps can be taken to make su
7/25/14 - Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR (sorafenib) in Patients with Advanced Breast Cancer
WHIPPANY, N.J. and SOUTH SAN FRANCISCO, Calif., July 25, 2014/ PRNewswire/ Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary, today announced that an investigational Phase 3 trial of NEXAVAR tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival. Joerg Moeller,
7/25/14 - Biogen Idec MA, Sunesis Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Biogen Idec MA, Weston, Massachusetts, and Sunesis Pharmaceuticals, South San Francisco, California, have been assigned a patent developed by 17 co-inventors for "bruton's tyrosine kinase inhibitors." The co-inventors are Minna Bui, Oakland, California, Patrick Conlon, Wakefield, Massachusetts, Julio H. Cuervo, Arlington,
7/25/14 - Clinical Investigator Training Course
The Food and Drug Administration's Center for Drug Evaluation and Research/ Office of Medical Policy and the Duke University Office of Continuing Medical Education are cosponsoring a 3- day training course for clinical investigators on scientific, ethical, and regulatory aspects of clinical trials. Senior FDA staff will communicate directly with...
7/25/14 - Cornerstone Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Cornerstone Pharmaceuticals, Cranbury, New Jersey, has been assigned a patent developed by Paul Bingham, Centereach, New York, Tom Kwok, Miller Place, New York, and Zuzana Zachar, Centereach, New York, for lipoic acid derivatives. The patent application was filed on April 17, 2008. Written by Sudarshan Harpal; edited by J
7/25/14 - Enanta Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Enanta Pharmaceuticals, Watertown, Massachusetts, has been assigned a patent developed by four co-inventors for "tetrazolyl macrocyclic hepatitis C serine protease inhibitors." The co-inventors are Ying Sun, Waltham, Massachusetts, Dong Liu, Waltham, Massachusetts, Yat Sun Or, Watertown, Massachusetts, and Zhe Wang, Hocke
7/25/14 - Erytech Pharma Reports Study of ERY-ASP in Acute Lymphoblastic Leukemia [Health & Beauty Close - Up]
Erytech Pharma reported the enrollment of the first patient in its Phase I/II study with ERY-ASP in Acute Lymphoblastic Leukemia in the United States of America. The study has been authorized by the FDA in 2013 and three centers are currently open for patient recruitment: The University of Chicago, Duke University Medical Center and Ohio State Univ
7/25/14 - Genentech Reports FDA Priority Review for Avastin [Health & Beauty Close - Up]
Genentech reported that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application and granted Priority Review for Avastin plus chemotherapy for the treatment of women with recurrent platinum- resistant ovarian cancer. "We look forward to working with the FDA to bring this potential option to women
7/25/14 - Infinity Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Infinity Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by eight co-inventors for cyclopamine analogs. The co-inventors are Brian Austad, Tewksbury, Massachusetts, Mark L. Behnke, Somerville, Massachusetts, Alfredo C. Castro, Winchester, Massachusetts, Michael J. Grogan, Winchester, Massac
7/25/14 - Infinity Pharmaceuticals Assigned Patent for Heterocyclic Compounds and Uses Thereof
ALEXANDRIA, Va., July 25 Infinity Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by 11 co-inventors for "heterocyclic compounds and uses thereof." The co-inventors are Alfredo C. Castro, Winchester, Massachusetts, Catherine A. Evans, Somerville, Massachusetts, Somarajannair Janardanannair, Woburn, Massachusetts, A
7/25/14 - Janssen Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Janssen Pharmaceuticals, Titusville, New Jersey, and Addex Pharma, Geneva, have been assigned a patent developed by four co-inventors for "imidazo pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors." The co-inventors are Andres Avelino Trabanco-Suarez, Toledo, Spain, Gary John Tresade
7/25/14 - Millennium Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Millennium Pharmaceuticals, Cambridge, Massachusetts, and Amgen British Columbia, Burnaby, Canada, have been assigned a patent developed by five co-inventors for "anti-GCC antibody molecules and related compositions and methods." The co-inventors are Samuel S. Nam, Haverhill, Massachusetts, Edward A. Greenfield, Stoughton
7/25/14 - Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration
Parnell Pharmaceuticals Holdings Ltd announces the successful licensing of two compounds that will be added to Parnell's already extensive pipeline through a license agreement with Australian-based CIMTECH Pty Ltd, a biotechnology company. "We are excited to have completed this deal with CIMTECH which we feel supports our proposition that we can
7/25/14 - Researchers Submit Patent Application, "Nutritional Formulations and Method for Treating Diseases", for Approval
By a News Reporter-Staff News Editor at Health& Medicine Week From Washington, D.C., NewsRx journalists report that a patent application by the inventor DUNNING, Barbara L., filed on December 28, 2012, was made available online on July 10, 2014. No assignee for this patent application has been made. News editors obtained the following quote from
7/25/14 - Researchers Submit Patent Application, "Stable Injectable Pharmaceutical Composition of Vitamin D Receptor Agonist and Process for Preparation...
Researchers Submit Patent Application, "Stable Injectable Pharmaceutical Composition of Vitamin D Receptor Agonist and Process for Preparation Thereof", for Approval. By a News Reporter-Staff News Editor at Drug Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors KOUTRIS, EFTHIMIOS; KARAVAS, EVANGELOS;
7/25/14 - Synta Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Synta Pharmaceuticals, Lexington, Massachusetts, has been assigned a patent developed by Dinesh U. Chimmanamada, Arlington, Massachusetts, and Weiwen Ying, Lexington, Massachusetts, for "pyrrole compounds that modulate HSP90 activity." Written by Deviprasad Jena; edited by Jaya Anand.
7/25/14 - Synta Pharmaceuticals Assigned Patent for Compounds for Treatment of Proliferative Disorders
ALEXANDRIA, Va., July 25 Synta Pharmaceuticals, Lexington, Massachusetts, has been assigned a patent developed by four co-inventors for "compounds for the treatment of proliferative disorders." The co-inventors are Keizo Koya, Chestnut Hill, Massachusetts, Lijun Sun, Harvard, Massachusetts, Shoujun Chen, Bedford, Massachusetts, and Jun Jiang, Nor
7/25/14 - Vertex Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., July 25 Vertex Pharmaceuticals, Boston, has been assigned a patent developed by 10 co-inventors for the "modulators of cystic fibrosis transmembrane conductance regulator." The co-inventors are Hayley Binch, Encinitas, California, Lev T.D. Fanning, San Marcos, California, Dennis Hurley, San Marcos, California, Urvi Sheth, San Die
7/25/14 - Vertex Pharmaceuticals Assigned Patent for Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide
ALEXANDRIA, Va., July 25 Vertex Pharmaceuticals, Boston, has been assigned a patent developed by six co-inventors for "solid forms of N- -1,4- dihydro-4-oxoquinoline- -3- carboxamide." The co-inventors are Sneha G. Arekar, Brighton, Massachusetts, Steven C. Johnston, Litchfield, New Hampshire, Mariusz Krawiec, Marlborough, Massachusetts, Ales Med
7/25/14 - Vertex Pharmaceuticals Assigned Patent for Thiazoles and Pyrazoles Useful as Kinase Inhibitors
ALEXANDRIA, Va., July 25 Vertex Pharmaceuticals, Boston, has been assigned a patent developed by five co-inventors for "thiazoles and pyrazoles useful as kinase inhibitors." The co-inventors are Michael Mortimore, Burford, United Kingdom, Julian Golec, Faringdon, United Kingdom, Christopher Davis, Salisbury, United Kingdom, Daniel Robinson, Abing
7/24/14 - "Glp-1 and Methods for Treating Diabetes" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Politics& Government Week A patent application by the inventor Steiness, Eva, filed on February 10, 2014, was made available online on July 10, 2014, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent application is assigned to Zealand Pharma A/s. See
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415